Clinical Trials
11 trialsNCT07290946 2025-12-18
MESRIX-more
Rigshospitalet, Denmark
Phase 2 Not yet recruiting
NCT02513238 2022-12-28
MESRIX
Rigshospitalet, Denmark
Phase 2 Completed
NCT00068237 2019-02-05
Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer
Radiation Therapy Oncology Group
Phase 2 Completed
NCT00352118 2017-12-28
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT01762514 2017-07-13
A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens
Sun Yat-sen University
Phase 2 Unknown
NCT00503776 2017-06-20
Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia
Vanderbilt-Ingram Cancer Center
Phase 2 Terminated
NCT00095927 2017-01-04
Randomized Amifostine For SCCHN
Dana-Farber Cancer Institute
Phase 2 Completed
NCT02854358 2016-08-03
Efficacy of Traditional Persian Medicine Preparation Versus Artificial Saliva for Radiation Induced Xerostomia
Shiraz University of Medical Sciences
Phase 2 Completed
NCT00168116 2016-02-24
Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure
AHS Cancer Control Alberta
Phase 2 Completed
NCT01682031 2014-08-22
Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy
Roswell Park Cancer Institute
Phase 2 Terminated
NCT00408759 2006-12-07
Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients
Bnai Zion Medical Center
Phase 2 Unknown